Aadi Bioscience Revenue and Competitors

0, CA USA

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Aadi Bioscience's estimated annual revenue is currently $16.6M per year.(i)
  • Aadi Bioscience's estimated revenue per employee is $276,417

Employee Data

  • Aadi Bioscience has 60 Employees.(i)
  • Aadi Bioscience grew their employee count by -30% last year.

Aadi Bioscience's People

NameTitleEmail/Phone
1
President and CEOReveal Email/Phone
2
Chief Financial OfficerReveal Email/Phone
3
Chief Medical OfficerReveal Email/Phone
4
VP Business Development & Corporate StrategyReveal Email/Phone
5
VP DevelopmentReveal Email/Phone
6
VP, Head Medical AffairsReveal Email/Phone
7
VP, Deputy General CounselReveal Email/Phone
8
Sr. Director, Nonclinical Regulatory AffairsReveal Email/Phone
9
Director Clinical OperationsReveal Email/Phone
10
Associate Director, Supply ChainReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$4.4M57-8%$53MN/A
#2
$21.2M137-26%$110MN/A
#3
$0.9M60%N/AN/A
#4
$2.3M1515%N/AN/A
#5
$1.6M10-17%N/AN/A
#6
$0.7M80%N/AN/A
#7
$11.5M74-12%N/AN/A
#8
$0.4M27510%$236.7MN/A
#9
$4M51-74%$160MN/A
#10
$2.3M1731%N/AN/A
Add Company

What Is Aadi Bioscience?

Aadi Bioscience Inc. (Aadi) is a biopharmaceutical company focused on precision therapies for genetically-defined cancers. We strive to unleash the potential of mTOR inhibition by employing precision medicine & nanoparticle technology to bring transformational therapies to cancer patients with mTOR pathway driver alterations. Our lead product has been FDA-approved for the treatment of adult patients with locally advanced unresectable or metastatic malignant perivascular epithelioid cell tumors (PEComa). Our world class leadership team is comprised of industry veterans from top biotech companies who have proven track records of bringing novel cancer therapies to market. A science-first mindset and patient-centric approach is in our genes. With a growing pipeline of studies, we remain dedicated to developing products for cancers with mTOR pathway driver alterations. For more information, please visit: https://aadibio.com/

keywords:N/A

N/A

Total Funding

60

Number of Employees

$16.6M

Revenue (est)

-30%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$15.7M609%N/A
#2
$17.6M605%N/A
#3
$8.6M6028%N/A
#4
$15M60-10%N/A
#5
$9.3M60-29%N/A